CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,226,945 | +13.6% | 93,125 | +13.2% | 0.00% | 0.0% |
| Q2 2023 | $3,721,796 | 0.0% | 82,286 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,721,796 | +20.6% | 82,286 | +8.4% | 0.00% | 0.0% |
| Q4 2022 | $3,085,579 | -99.9% | 75,906 | +0.2% | 0.00% | -33.3% |
| Q3 2022 | $4,952,615,000 | -38.8% | 75,786 | -43.1% | 0.00% | -25.0% |
| Q2 2022 | $8,091,770,000 | +8.0% | 133,154 | +11.6% | 0.00% | +33.3% |
| Q1 2022 | $7,490,156,000 | -17.3% | 119,327 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $9,058,212,000 | -29.3% | 119,533 | +4.5% | 0.00% | -40.0% |
| Q3 2021 | $12,807,032,000 | -32.5% | 114,420 | -2.4% | 0.01% | -37.5% |
| Q2 2021 | $18,975,612,000 | +10.4% | 117,213 | -16.9% | 0.01% | 0.0% |
| Q1 2021 | $17,187,429,000 | +5.2% | 141,054 | +32.1% | 0.01% | 0.0% |
| Q4 2020 | $16,343,881,000 | +62.0% | 106,746 | -11.5% | 0.01% | +60.0% |
| Q3 2020 | $10,086,316,000 | -1.3% | 120,592 | -13.3% | 0.01% | -16.7% |
| Q2 2020 | $10,217,314,000 | +84.9% | 139,030 | +6.7% | 0.01% | +50.0% |
| Q1 2020 | $5,527,211,000 | – | 130,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |